These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 522698)

  • 1. Sulindac, reactive oxygen, and arthritis.
    Bodaness RS
    Med Hypotheses; 1979 Oct; 5(10):1129-30. PubMed ID: 522698
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulindac (Clinoril)--a new drug for arthritis.
    Med Lett Drugs Ther; 1979 Jan; 21(1):1-2. PubMed ID: 759836
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of Sulindac.
    Kwan KC; Duggan DE
    Acta Rhumatol Belg; 1977; 1(3-4):168-78. PubMed ID: 756665
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative disposition of sulindac and metabolites in five species.
    Duggan DE; Hooke KF; Noll RM; Hucker HB; Van Arman CG
    Biochem Pharmacol; 1978; 27(19):2311-20. PubMed ID: 103551
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agent.
    Miller MJ; Bednar MM; McGiff JC
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():487-91. PubMed ID: 6221568
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
    Duggan DE
    Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
    Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
    Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac. A potentially renal-sparing nonsteroidal anti-inflammatory drug.
    Bunning RD; Barth WF
    JAMA; 1982 Dec; 248(21):2864-7. PubMed ID: 7143649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparing effect of sulindac on lithium levels.
    Miller LG; Bowman RC; Bakht F
    J Fam Pract; 1989 May; 28(5):592-3. PubMed ID: 2715775
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the effect of fenbufen and sulindac on type II collagen-induced arthritis in rats.
    Kerwar SS; Sloboda AE
    Agents Actions; 1982 Apr; 12(1-2):216-20. PubMed ID: 7080959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac in the treatment of acute gout arthritis.
    Karachalios GN; Donas G
    Int J Tissue React; 1982; 4(4):297-9. PubMed ID: 7169301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl sulfoxide inhibits metabolic activation of sulindac.
    Swanson BN; Mojaverian P; Boppana VK; Vlasses PH; Ferguson RK
    Ann N Y Acad Sci; 1983; 411():381-2. PubMed ID: 6576719
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
    Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
    J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Publicity about sulindac.
    N Engl J Med; 1979 Mar; 300(13):734-5. PubMed ID: 763308
    [No Abstract]   [Full Text] [Related]  

  • 15. Dimethyl sulfoxide inhibits bioactivation of sulindac.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study.
    Fan SS; Shen TY
    J Med Chem; 1981 Oct; 24(10):1197-202. PubMed ID: 6276543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac causing a hypersensitivity reaction with peripheral and mediastinal lymphadenopathy.
    Sprung DJ
    Ann Intern Med; 1982 Oct; 97(4):564. PubMed ID: 7125415
    [No Abstract]   [Full Text] [Related]  

  • 18. Biliary secretion of sulindac and metabolites in man.
    Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE
    Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen and sulindac kinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB
    Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of graded oral doses of sulindac in man.
    Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
    Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.